Menu
More in this section:

Clinical Trials

 

The Research division of the Kolschowsky Institute is dedicated to advancing medicine by connecting patients with innovative therapies that are not yet widely available. With more than 160 active clinical research trials across diverse specialties including cardiology, infectious disease, gastroenterology, neurology, oncology, pulmonology, urology, vascular health, and more. By participating in research, patients gain access to cutting edge treatment options and also play a vital role in shaping the future of healthcare. To learn more about current trials and how you can get involved, contact the Research Team.

Click here to view a list of all active clincial trials 

 

Featured Studies:

Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer Thursday, October 2, 20250

Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer

Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.

Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer Thursday, October 2, 20250

Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

The Kolschowsky Research and Education Institute joins clinical trial testing the efficacy of an experimental immunotherapeutic drug, Olvi-Vec, used in combination with FDA-approved platinum-based chemotherapy and targeted therapy drug bevacizumab.

Investigational Device May Help Minimize Bleeding, Other Complications in Patients Undergoing Dialysis Thursday, October 2, 20250

Investigational Device May Help Minimize Bleeding, Other Complications in Patients Undergoing Dialysis

Sarasota Memorials Kolschowsky Research and Education Institute is among 10 research sites studying an investigational device designed to reduce the risk of bleeding complications in patients undergoing hemodialysis treatment.

Clinical Study of Nanosecond Pulsed Field Ablation for People with Benign Thyroid Nodules Tuesday, September 30, 20250

Clinical Study of Nanosecond Pulsed Field Ablation for People with Benign Thyroid Nodules

The PRECISE-BTN study uses Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA) technology to treat patients with benign thyroid nodules (BTNs). 

Clinical Trial for Patients with Genetic Risk for Heart Disease Wednesday, September 24, 20250

Clinical Trial for Patients with Genetic Risk for Heart Disease

Clinical trial testing whether an investigational drug could reduce heart attacks and mortality in individuals with a specific genetic variant following a sudden cardiac event.

RSS